glp-1 molecular structure Glucagon-like peptide 1 (1-37) GLP-1 Drugs and the Physiology

11.Novo Nordisk Internet

As research on GLP-1RAs expands in the cognitive and mental health area, we may be able to distinguish between direct effects on cognitive and mental health outcomes and effects that are mediated by GLP-1RAs actions on cardiovascular and metabolic outcomes

FDA labels for these medications include warnings about the risk of dehydration and acute kidney injury, particularly during episodes of significant gastrointestinal illness

[Source: Fierce Pharma ] January 2025 The FDA fast-tracked tirzepatide for cardiovascular risk reduction in obesity patients, following landmark trial results showing significant benefit beyond weight loss

While each plan may differ in the details, many insurers will only cover these medications for patients with a diagnosis of Type 2 Diabetes or those whose plans include specific weight management benefits

Established clinics, staffed by clinicians who live here